Sigma-Aldrich Company Profile (NASDAQ:SIAL)

About Sigma-Aldrich

Sigma-Aldrich logoSigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes a range of biochemical and organic chemical products, kits and services that are used in scientific research. It manufactures and distributes around 250,000 chemicals, biochemical and other essential products and approximately 46,000 equipment products. Its business unit structure is aligned into three business units: Research, Applied and SAFC Commercial. Its brands include Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haen, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. It offers its products and services to research and applied labs, pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies and non-profit organizations, among others. It operates in around 37 countries and sells into approximately 160 countries.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: Specialty Chemicals
  • Sub-Industry: Specialty Chemicals
  • Exchange: NASDAQ
  • Symbol: SIAL
  • CUSIP: 82655210
Key Metrics:
  • Previous Close: $139.76
  • 50 Day Moving Average: $139.63
  • 200 Day Moving Average: $139.40
  • 52-Week Range: $135.33 - $140.03
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 31.41
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to Sigma-Aldrich:

Analyst Ratings

Consensus Ratings for Sigma-Aldrich (NASDAQ:SIAL) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Sigma-Aldrich (NASDAQ:SIAL)
No equities research coverage for this company has been tracked by


Earnings History for Sigma-Aldrich (NASDAQ:SIAL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2015Q3 15$1.06$1.00ViewN/AView Earnings Details
7/30/2015Q2$1.12$1.01ViewN/AView Earnings Details
5/7/2015Q115$1.08$1.06$685.23 million$676.00 millionViewN/AView Earnings Details
2/12/2015Q414$1.09$1.14$705.00 millionViewN/AView Earnings Details
10/23/2014Q314$1.06$1.06$689.82 million$5.90 billionViewN/AView Earnings Details
7/24/2014Q214$1.11$1.11$706.14 million$701.00 millionViewN/AView Earnings Details
4/24/2014Q114$1.03$1.06$690.60 million$689.00 millionViewListenView Earnings Details
2/6/2014Q413$1.01$1.02$675.97 million$684.00 millionViewListenView Earnings Details
10/22/2013Q313$0.99$1.05$661.29 million$664.00 millionViewN/AView Earnings Details
7/23/2013Q2 2013$1.04$1.05$679.50 million$681.00 millionViewN/AView Earnings Details
4/25/2013Q1 2013$1.01$1.03$672.89 million$675.00 millionViewN/AView Earnings Details
2/7/2013Q4 2012$0.95$0.96$659.55 million$655.00 millionViewN/AView Earnings Details
10/23/2012$0.94$0.94ViewN/AView Earnings Details
7/24/2012$0.97$0.97ViewN/AView Earnings Details
4/24/2012$0.99$0.99ViewN/AView Earnings Details
2/9/2012$0.89$0.91ViewN/AView Earnings Details
10/25/2011$0.91$0.96ViewN/AView Earnings Details
7/26/2011$0.92$0.91ViewN/AView Earnings Details
4/26/2011$0.90$0.94ViewN/AView Earnings Details
2/9/2011$0.80$0.83ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Sigma-Aldrich (NASDAQ:SIAL)
Current Year EPS Consensus Estimate: $4.15 EPS
Next Year EPS Consensus Estimate: $4.45 EPS


Current Dividend Information for Sigma-Aldrich (NASDAQ:SIAL)
Annual Dividend:$0.00
Dividend Yield:0.00%
Dividend Growth:-4.80% (3 Year Average)
Payout Ratio:0.00% (Based on Current Year Consensus EPS Estimate)
0.00% (Based on Next Year Consensus EPS Estimate)
Track Record:40 Years of Consecutive Dividend Growth

Dividend History for Sigma-Aldrich (NASDAQ:SIAL)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Sigma-Aldrich (NASDAQ:SIAL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/26/2015J Pedro ReinhardDirectorSell3,000$139.77$419,310.00View SEC Filing  
6/17/2015J Pedro ReinhardDirectorSell6,000$139.35$836,100.00View SEC Filing  
3/11/2015George Lloyd MillerSVPSell7,095$137.89$978,329.55View SEC Filing  
11/5/2014Lee MccollumDirectorSell10,000$135.26$1,352,600.00View SEC Filing  
7/28/2014Karen J MillerSVPSell7,943$103.19$819,638.17View SEC Filing  
5/29/2014Eric Mark GreenEVPSell4,544$98.03$445,448.32View SEC Filing  
5/28/2014Gilles CottierEVPSell12,000$98.10$1,177,200.00View SEC Filing  
4/28/2014Frank WicksEVPSell5,443$95.21$518,228.03View SEC Filing  
3/4/2014Douglas RauVPSell15,100$93.53$1,412,303.00View SEC Filing  
2/24/2014J Pedro ReinhardDirectorSell2,450$93.52$229,124.00View SEC Filing  
2/19/2014Karen MillerSVPSell1,133$95.62$108,337.46View SEC Filing  
2/14/2014Barrett ToanDirectorSell18,000$96.35$1,734,300.00View SEC Filing  
2/11/2014Gilles CottierEVPSell28,600$94.00$2,688,400.00View SEC Filing  
12/4/2013Avi NashDirectorSell3,100$88.00$272,800.00View SEC Filing  
12/3/2013Karen MillerSVPSell7,100$86.90$616,990.00View SEC Filing  
11/26/2013Avi NashDirectorSell10,000$87.13$871,300.00View SEC Filing  
9/4/2013Jan BertschCFOBuy1,204$83.04$99,980.16View SEC Filing  
9/4/2013Lee MccollumDirectorSell7,400$83.44$617,456.00View SEC Filing  
5/28/2013Gilles CottierEVPSell5,981$85.30$510,179.30View SEC Filing  
5/22/2013Gilles CottierEVPSell5,319$85.03$452,274.57View SEC Filing  
5/22/2013Karen J MillerSVPSell2,713$85.00$230,605.00View SEC Filing  
5/15/2013Eric Mark GreenEVPSell3,900$83.05$323,895.00View SEC Filing  
2/15/2013George Lloyd MillerSVPBuy1,000$76.92$76,920.00View SEC Filing  
11/1/2012Jan BertschCFOBuy1,500$70.60$105,900.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Sigma-Aldrich (NASDAQ:SIAL)
DateHeadline logoMerck KGaA (MKGAF) Q2 Earnings Fall, Guides Up on Sales (NASDAQ:SIAL) - August 5 at 10:27 AM logo[$$] Merck KGaA Lifts Profit Outlook as Sales Jump (NASDAQ:SIAL) - August 4 at 10:36 AM logoGermany's Merck Lifts Full-Year Forecasts After Sigma-Aldrich Purchase (NASDAQ:SIAL) - August 4 at 10:36 AM logoMerck KGaA (MKGAF) Q2 Earnings Fall But View Raised (NASDAQ:SIAL) - August 4 at 10:36 AM logoMerck Is Deleveraging Faster Than I Expected After An Excellent First Quarter (NASDAQ:SIAL) - June 17 at 7:06 PM logoSigma-Aldrich Corporation (SIAL) - Medical Equipment - Deals and Alliances Profile - New Market Research Report (NASDAQ:SIAL) - June 13 at 10:21 AM logoAGM Trading and Operations Update (NASDAQ:SIAL) - June 9 at 3:09 AM logoMerck KGaA's Q1 Earnings Increase Y/Y, Offers 2016 View (NASDAQ:SIAL) - May 20 at 10:33 AM logoMerck KGaA (MKGAF) Q1 Earnings Increased Y/Y (NASDAQ:SIAL) - May 19 at 3:24 AM logo[$$] Germany's Merck Lifted by Sigma-Aldrich Deal (NASDAQ:SIAL) - May 19 at 2:50 AM logoMerck Increases Sales and Earnings in Q1 Following Sigma-Aldrich Acquisition (NASDAQ:SIAL) - May 19 at 2:32 AM logoAnnual Report & Accounts and Notice of Meeting (NASDAQ:SIAL) - April 15 at 2:14 AM
News IconCurrent Price Targets For Sigma-Aldrich Corporation (NASDAQ:SIAL) - Risers & Fallers (NASDAQ:SIAL) - April 9 at 2:12 PM
News IconNew report shares details about Sigma-Aldrich corporation (SIAL) market to financial and strategic SWOT analysis & forecast (NASDAQ:SIAL) - March 15 at 1:05 PM logo[$$] Germany's Merck Boosted by Life Sciences (NASDAQ:SIAL) - March 8 at 5:22 AM logoMerck KGaA (MKGAF) Q4 Earnings Decline Y/Y (NASDAQ:SIAL) - March 8 at 4:02 AM logoDIRECTORS/PDMR SHAREHOLDING (NASDAQ:SIAL) - January 11 at 3:49 PM logoManagement Changes (NASDAQ:SIAL) - December 17 at 2:31 AM logoFormer Sigma-Aldrich CEO named chief executive of Florida firm (NASDAQ:SIAL) - December 16 at 12:35 PM logoMerck KGaA Said to Weigh Selling its Allergy Therapy Unit (NASDAQ:SIAL) - November 26 at 3:35 PM logoThese 5 Stocks Dominate Farallon Capital’s Portfolio (NASDAQ:SIAL) - November 22 at 12:40 PM logoSIGMA ALDRICH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:SIAL) - November 18 at 4:32 PM logoMerck Completes Sigma-Aldrich Acquisition (NASDAQ:SIAL) - November 18 at 8:25 AM logoTrading and Operations Update – 18 November 2015 (NASDAQ:SIAL) - November 18 at 2:26 AM logoIllumina Set to Join the S&P 500 (NASDAQ:SIAL) - November 12 at 6:44 PM logoDividend Aristocrats Part 23 of 52: Sigma-Aldrich Corporation (SIAL) (NASDAQ:SIAL) - November 12 at 2:51 PM logo[$$] Germany's Merck: Tooling Up for Biotech Gold Rush (NASDAQ:SIAL) - November 12 at 11:35 AM


Sigma-Aldrich (NASDAQ:SIAL) Chart for Saturday, October, 22, 2016

Last Updated on 10/22/2016 by Staff